Now showing items 1-10 of 33
Behçet Disease With Vascular Involvement
Vascular involvement is one of the major causes of mortality and morbidity in Behçet disease (BD). There are no controlled studies for the management of vascular BD (VBD), and according to the EULAR recommendations, only ...
Covid-19 Pandemi Raporu (20 Mart-20 Kasım 2020)
(Hacettepe İç Hastalıkları Derneği, 2021)
31 Aralık 2019 tarihinde Çin’de ortaya çıkan ve kısa sürede tüm dünyayı etkileyen SARS-Coronavirus-2 etkenine bağlı COVID-19’un Dünya Sağlık Örgütü tarafından pandemi ilan edildiği dönem ile eş zamanlı olarak, ülkemizde ...
Comment on: Microscopic Polyangiitis: Clinical Characteristics and Long-Term Outcomes of 378 Patients From The French Vasculitis Study Group Registry By Nguyen Et Al
Comments on Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry by Nguyen et al
Imaging Modalities Used in Diagnosis and Follow-Up of Patients with Takayasu’s Arteritis
(Turk J Med SciTÜBİTAK, 2021-02-26)
Background/aim: Takayasu’s arteritis (TA) is a rare, large-vessel vasculitis of unknown etiology, affecting aortic arch, and its main branches. Noninvasive imaging methods are frequently used in diagnosis and follow-up in ...
Which Definition Should be used to Determine Colchicine Resistance Among Patients with Familial Mediterranean Fever?
(Clin Exp Rheumatol, 2018-11-12)
Objectives: Colchicine is the main therapy for familial Mediterranean fever (FMF); however, 5-10% of patients are colchicine-resistant. There is no standard and validated definition for colchicine resistance. We aimed to ...
Management of Behcet's syndrome
Abstract Behcet's syndrome (BS) is a variable vessel vasculitis with heterogeneous clinical features. Skin, mucosa and joint involvement can cause impairment of quality of life but do not cause permanent damage whereas ...
Adalimumab as Treatment for Venous Thrombosis in Behçet's Syndrome: Comment on the Article by Emmi et al
We read with interest the article by Emmi et al 1 regarding the effect of adalimumab (ADA)–based treatment versus disease‐modifying antirheumatic drug (DMARD) therapy for venous thrombosis in Behçet's syndrome (BS). Their ...
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes
Objectives: ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show that differences in disease presentation and 6 month outcome between younger- and older-onset patients are still incompletely ...
Polyarteritis nodosa: lessons from 25 years of experience
(Clin Exp Rheumatol, 2018-10-30)
Objectives: Polyarteritis nodosa is a necrotising vasculitis of predominantly medium size vessels. The present study aimed to summarise the characteristics of PAN patients, and also analyse the trend of decreasing PAN ...
Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry
Objective Psoriatic Arthritis Impact of Disease 12-item questionnaire (PsAID-12) has been developed to be used in psoriatic arthritis in daily practice. The aim of the present study was to assess the change values of ...